The Self Match Study: A Study of Informed Choice in the Treatment of Addiction

October 26, 2021 updated by: Kjeld Andersen

A Randomized Controlled Study of Patients Matching Themselves to Treatment Options: The Self-Match Study

The purpose of this study is to determine whether patient self-matching (as compared with treatment as usual by expert matching) improves quality of life, retention, and outcome for patients being treated for alcohol problems.

There are at least two good reasons for offering patients a choice when the goal is a change in their behavior. The first is that patients are likely to know what treatment works best for them. Secondly, being allowed to choose between options may increase compliance in treatment. As a randomized controlled trial, this study will compare the efficacy of patient self-matching versus treatment-as-usual expert matching.

The Self-Match Study is expected to increase knowledge on the importance of involving the alcohol dependent patient in choosing what treatment method is best for him/her instead of having experts to do that. The investigators expect to discover patient involvement as a way to improve compliance in treatment, hence preventing that patients drop out of treatment to early. If this hypothesis proves to be right, clinicians will have a viable strategy for matching treatment methods to patients, since the strategy does not demand further resources in the treatment system.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Odense, Denmark, DK - 5000 C
        • RESCueH alcohol Studies, Unit of Clinical Alcohol Research, Psyciatric Research Unit, Clinical Institute, University of Southern Denmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Fulfilling DSM-IV criteria for alcohol abuse or dependence.
  2. Native Danish speaking.
  3. Having no severe psychosis or cognitive impairment.
  4. Accepting to participate in the study.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Self Match
The patient must choose between the five possible treatment options.
Video presentation of treatment option are shown to the patient whereafter the patient must choose between the five possible treatment options.
Active Comparator: Expert Match
The Patient is referred to treatment by standard procedure which is Expert Match based on patient data.
Referral as usual to one of five possible treatment options. The referral is based on baseline data from the patient and by the means of an algorithm, used in daily clinical praxis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduced amount of drinking days measured by Time Line Follow Back.
Time Frame: 6 months after initiation of treatment.
The primary endpoint analysis will be a comparison of outcomes for patients assigned to the self-match group vs. expert-match group to determine whether self-matching yields more favorable outcome than expert matching, measured by the number of excessive drinking days.
6 months after initiation of treatment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compliance measured by proportion of patients who has completed treatment.
Time Frame: 6 months after treatment start
Data on patients who have completed treatment as planned will be gathered from treatment journal.
6 months after treatment start
Quality of life measured by WHO's Quality of Life scale.
Time Frame: 6 months after treatment start.
Patients reporting increase or decrease in quality of life compared to baseline.
6 months after treatment start.
Personality traits, measured by NEO-FFI-3, influence on outcome.
Time Frame: 6 months after treatment start.
Comparison of personality traits with outcome measures.
6 months after treatment start.
Deviation in the chosen treatment in the Self-Match group in relation to the expected expert choice.
Time Frame: 6 months after treatment start.
The algorithm score used in expert-matching will be calculated for all patients. The chosen treatment for patients in The Self-Match Group will be compared to the algorithm score to measure convergence between Self-Match and Expert-Match.
6 months after treatment start.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

November 1, 2019

Study Completion (Actual)

January 29, 2021

Study Registration Dates

First Submitted

March 29, 2017

First Submitted That Met QC Criteria

September 8, 2017

First Posted (Actual)

September 12, 2017

Study Record Updates

Last Update Posted (Actual)

October 27, 2021

Last Update Submitted That Met QC Criteria

October 26, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Dependence

Clinical Trials on Self Match

Subscribe